News
Business
Economy
Politics
Technology
Environment
Search
Thursday, October 17, 2024
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer’s drug
FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant
FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar
- Advertisment -
Most Read
Apple launches new iPad mini with AI features
October 15, 2024
China may raise $850 billion in new debt over three years to spur growth, says report
October 15, 2024
Under fire, Trump contends economic policies won’t boost federal debt
October 15, 2024
Intel, AMD team up to confront rising challenge from Arm
October 15, 2024
We use cookies to ensure that we give you the best experience on our website.
Ok